Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes

Cancer Immunol Immunother. 1986;22(2):132-8. doi: 10.1007/BF00199127.

Abstract

BALB/c mouse peritoneal macrophages prepared from WPC which had been treated with N. CWS demonstrated potent cytostatic activity against syngeneic Meth A fibrosarcoma cells. The maximum cytostatic activity developed in the macrophages when WPC were incubated with 25 micrograms/ml N. CWS for 3 days. NAPC from BALB/c mice given an i.p. injection with 100 micrograms N. CWS 7 days previously (N. CWS-NAPC) or supernatants from N. CWS-NAPC also activated peritoneal macrophages in vitro. However, when peritoneal macrophages were incubated with N. CWS in the absence of NAPC, or when T cells were depleted from WPC by treatment with anti-Thy 1.2 antibody and complement, N. CWS failed to enhance the cytostatic activity of the macrophages. Furthermore, thioglycollate-elicited peritoneal macrophages from C3H/HeN mice increased their cytolytic properties by incubation with supernatant fluids from N. CWS-treated spleen cells. These findings suggest that in vitro macrophage activation with N. CWS depends on MAF secreted from T lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion
  • Cell Separation
  • Cell Wall / immunology
  • Cell-Free System
  • Lymphocytes / metabolism*
  • Lymphokines / biosynthesis*
  • Macrophage Activation*
  • Macrophage-Activating Factors
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C3H
  • Nocardia / immunology*
  • Peritoneal Cavity / cytology
  • Spleen / cytology
  • T-Lymphocytes / immunology

Substances

  • Lymphokines
  • Macrophage-Activating Factors